If Janssen hasn't moved to license or put cash forward for an extension by 2H it would be a point of concern. Roche also had a February date in 2013 with anticipated move to license which just drifted past the Feb crux & Pfizer also looking at early 2013. They only delivered the end of AZ/Roche/Pfizer agreements slipped into the annual report lets hope it doesn't play out the same.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.26 |
Change
-0.035(2.70%) |
Mkt cap ! $734.9M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.26 | $2.681M | 2.075M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 3081 | $1.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.30 | 700 | 1 |
View Market Depth
| Last trade - 16.11pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |